Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-22T18:03:40.703Z Has data issue: false hasContentIssue false
  • English
  • Français

Amitriptyline in Depressive States

Phenomenology and Prognostic Considerations

Published online by Cambridge University Press:  29 January 2018

Anthony Hordern ,
N. F. Holt ,
C. G. Burt  and
W. F. Gordon
Anthony Hordern
Affiliation:
Mental Health Research Institute
N. F. Holt
Affiliation:
Mental Health Research Institute
C. G. Burt
Affiliation:
Royal Park Psychiatric Hospital
W. F. Gordon
Affiliation:
Royal Park Psychiatric Hospital Victoria, Australia
Get access Rights & Permissions [Opens in a new window]

Extract

In recent years the development of effective anti-depressant drugs has led to much controversy and uncertainty regarding the treatment of depressive states. Indications for the primary use of E.C.T. remain obscure, whilst choice of drug seems to be determined by current personal preference rather than by any specific rationale. If reliable prognostic formulations—and so, rational lines of treatment—are to be developed, there is an urgent need for the accumulation of data from controlled trials rather than a continuing spate of “1”.

Amitriptyline, a new anti-depressant chemically resembling both imipramine and chlorpromazine has, in a blind controlled study carried out by the authors, been shown to be significantly superior to imipramine in the treatment of female patients between 30 and 70 years of age, hospitalized with primary depressive states (Burt, Gordon, Holt and Hordern, 1962). The findings in the first 74 patients were unexpectedly so much in favour of amitriptyline that to confirm them the trial was extended to include a further 65 patients conforming to the same criteria; but as two died, the total sample consisted of 137 female patients. The size of this sample facilitated (1) an investigation of the phenomenology of depressive states in women and (2) a study of the significance of a number of prognostic variables in relation to the outcome of treatment with amitriptyline and imipramine.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 109 , Issue 463 , November 1963 , pp. 815 - 825
Copyright
Copyright © Royal College of Psychiatrists, 1963 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ayd, F. J. (1961). “A critique of antidepressants.” Dis. Nerv. Syst., 22, 32–36, Suppl.Google Scholar
Burt, C. G., Gordon, W. F., Holt, N. F., and Hordern, A. (1962). “Amitriptyline in depressive states: a controlled trial.” J. Ment. Sci., 108, 711–730.Google Scholar
Busfield, B. L., Schnellar, P., and Capra, D. (1962). “Depressive symptom or side-effect? A comparative study of symptoms during pre-treatment and treatment periods of patients on three anti-depressant medications.” J. Nerv. Ment. Dis., 134, 339.CrossRefGoogle Scholar
Cares, R. M., and Buckman, C. (1961). “A survey of side-effects and/or toxicity of newer psychopharmacologic agents.” Dis. Nerv. Syst., 22, 97–106, Suppl. Google Scholar
Friedman, C., Mowbray, M. S., and Hamilton, V. J. (1961). “Imipramine (Tofranil) in depressive states.” J. Ment. Sci., 107, 948–953.Google Scholar
Hamilton, M. (1960). “A rating scale for depression.” J. Neurol. Neurosurg. Psychiat., 23, 56–62.CrossRefGoogle Scholar
Hamilton, M. and White, J. M. (1960). “Factors related to the outcome of depression treated with E.C.T.” J. Ment. Sci., 106, 1031–1041.CrossRefGoogle Scholar
Hobson, R. F. (1953). “Prognostic factors in electroconvulsive therapy.” J. Neurol. Neurosurg. Psychiat., 16, 275–281.CrossRefGoogle Scholar
Kristiansen, E. S. (1961). “Cardiac complications during treatment with imipramine (Tofranil).” Acta Psychiat. et Neurol. Scand., 36, 427–442.Google Scholar
Pollitt, J. D. (1960). “Depression and the functional shift.” Comprehen. Psychiat., 1, 381–390.Google Scholar
Rees, L., Brown, A. C., and Benaim, S. (1961). “A controlled trial of imipramine (Tofranil) in the treatment of severe depressive states.” J. Ment. Sci., 107, 552–559.Google Scholar
Roberts, J. M. (1959). “Prognostic factors in the electroshock treatment of depressive states.” ibid., 105, 693–702.Google Scholar
Robin, A. A., and Harris, J. A. (1962). “A controlled comparison of imipramine and electroplexy.” ibid., 108, 217–219.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.